GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway

Wanli Zhang1, Weikuan Sun1, Xiaofan Gu1

  • 1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.

Cell Death Discovery
|April 5, 2022
PubMed

Insights

Growth differentiation factor 15 (GDF-15) in tumor exosomes promotes cancer cachexia by inducing muscle atrophy. Targeting GDF-15 may offer a therapeutic strategy for this debilitating condition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer cachexia is a complex syndrome causing significant muscle loss.
  • Tumor-derived exosomes are implicated in cancer cachexia pathogenesis.
  • Previous research identified microRNAs in exosomes contributing to muscle atrophy.

Purpose of the Study:

  • To investigate the role of proteins within tumor-derived exosomes in cancer cachexia.
  • To identify specific exosomal proteins that induce muscle atrophy.

Main Methods:

  • Comparative proteomic analysis of exosomes from cachectic (C26) and non-cachectic (MC38) tumor cells.
  • Western blotting to validate protein expression levels.
  • In vitro studies using C2C12 myotubes to assess GDF-15's direct effects.
  • In vivo studies in tumor-bearing mice.
  • Genetic manipulation (overexpression and knockdown) of GDF-15 in cancer cells.

Main Results:

  • Growth differentiation factor 15 (GDF-15) was significantly elevated in exosomes from cachectic C26 tumor cells compared to non-cachectic MC38 cells.
  • GDF-15 directly induced muscle atrophy in cultured myotubes by modulating Bcl-2/caspase-3 pathways.
  • Overexpression of GDF-15 enhanced the muscle-atrophying potential of tumor-derived factors, while its knockdown reduced this potential.
  • GDF-15 was also found in tumor tissues, serum exosomes, and muscle tissues of tumor-bearing mice.

Conclusions:

  • GDF-15, present in tumor-derived exosomes, plays a crucial role in inducing muscle atrophy associated with cancer cachexia.
  • GDF-15 represents a potential therapeutic target for managing cancer cachexia.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K